Patient preference in allergen immunotherapy - Understanding the patient's view
Authors:
- Sven BeckerSBSven Becker
- Martin FeindorMFMartin Feindor
- Anke GraesselAGAnke Graessel
- Isabel Fernández de AlbaIAIsabel Fernández de Alba
- Katrin BirkholzKBKatrin Birkholz
- Jennifer RaabJRJennifer Raab
- Filippo FassioFFFilippo Fassio
- Dolores HernandezDHDolores Hernandez
- Neil ValentineNVNeil Valentine
- Robin AbroRARobin Abro
- Oliver FuchsOFOliver Fuchs
- Simon BlankSimon Blank
Open Access
- 13 December 2025
- journal article
- Published by Elsevier in World Allergy Organization Journal
- Vol. 18 (12)
Abstract
No abstract availableKeywords
Funding Information
- Allergy Therapeutics PLC
This publication has 46 references indexed in Scilit:
- Extension and validation of a physiologically based toxicokinetic model for risk assessment of aluminium exposure in humansArchives of Toxicology, 2025
- Toxicokinetics of aluminium—novel insights in an old adjuvantAllergo Journal International, 2024
- Elevated aluminum excretion in patients by long-term subcutaneous immunotherapy – A cross-sectional case-control studyInternational Journal of Hygiene and Environmental Health, 2024
- Why do patients not stick with IT?Annals of Allergy, Asthma & Immunology, 2022
- Physiology-based toxicokinetic modelling of aluminium in rat and manArchives of Toxicology, 2021
- Shared decision making for the allergistAnnals of Allergy, Asthma & Immunology, 2019
- Patient preferences for route of allergy immunotherapy: a comparison of four delivery methodsInternational Forum of Allergy & Rhinology, 2016
- How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort studyEuropean Journal of Pediatrics, 2014
- Häufigkeit allergischer Erkrankungen in DeutschlandBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2013
- Patient Preferences and Health DisparitiesJAMA, 2001